Clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers.
Get notified the moment Revolution Medicines files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.